James H. O'Keefe Jr., MD - Professor of Medicine, University of Missouri at Kansas City, Mid-America Heart Institute, St. Lukes Hospital

James H. O'Keefe, Jr., M.D., is Director of Preventive Cardiology at the Mid America Heart Institute and Professor of Medicine at the University of Missouri in Kansas City. His postgraduate training included a cardiology fellowship at Mayo Clinic in Rochester, Minnesota. He has written 135 articles and 6 books on cardiovascular medicine, and he lectures extensively on the role of therapeutic lifestyle changes and drug therapy in cardiovascular risk reduction. He is actively involved in patient care. 

David S.H. Bell, MD, FACP - Clinical Professor of Medicine, University of Birmingham School of Medicine, Birmingham, Alabama

David S. H. Bell, MB, is Clinical Professor of Medicine at the University of Alabama at Birmingham, School of Medicine, and a leading authority on the prevention and treatment of type 2 diabetes. During his  distinguished career, he  has contributed more than 230 articles to the medical literature. He is an active researcher and has served as Director of the Endocrine Clinical Research Program at the University of Alabama Birmingham. Dr. Bell speaks nationally and internationally on the treatment of type 2 diabetes and its complications, and he is currently a member of the editorial boards of Endocrine Practice, Treatments in Endocrinology, Diabetes, and Obesity and Metabolism. He is a recipient of the Distinguished Clinician Award from the American College of Endocrinology for outstanding contribution as a master educator and clinician and the Seale Harris Award from the Southern Medical Association for outstanding contributions to diabetes research.   

Kathleen L. Wyne, MD, PhD - Assistant Professor, Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas
Kathleen L. Wyne, MD, PhD, is an Assistant Professor in the Division of Endocrinology and Metabolism at the University of Texas Southwestern Medical Center, Dallas, Texas. She is actively involved in basic science and clinical research, and her main research interests include the role of lipid metabolism in the etiology of diabetes and genetic causes of beta cell defects. In 1999 she received a Career Development Award from the Juvenile Diabetes Research Foundation International, and in 2000 she received a research grant from the same organization. Dr. Wyne has contributed many articles to the medical literature and lectures extensively on lipid metabolism and diabetes treatment. She is actively involved in patient care.